Kathryn Elenchin, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 116 Interstate Pkwy, Bradford, PA 16701 Phone: 814-362-8674 |
Nancy Elizabeth O'day, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 116 Interstate Pkwy, Bradford Regional Medical Center, Bradford, PA 16701 Phone: 814-362-8674 Fax: 814-362-8695 |
David Hefferan, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 116 Interstate Pkwy, Bradford, PA 16701 Phone: 814-362-8764 |
Gregory Thomas Blatz, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 110 N Bennett St, Bradford, PA 16701 Phone: 814-368-8869 |
Ann Sassone Tommasino, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 116 Interstate Pkwy, Bradford, PA 16701 Phone: 814-362-8674 Fax: 814-362-8695 |
News Archive
The Health Resources and Services Administration (HRSA) today announced awards of $5.1 million to provide training and technical assistance (TA) as part of the Ryan White HIV/AIDS Program, which provides HIV-related services in the United States for those who do not have sufficient health care coverage or financial resources for coping with HIV disease.
A. Alfred Taubman has become U-M's largest individual donor, with total giving of more than $142 million. His latest gift of $56 million to the A. Alfred Taubman Medical Research Institute, announced today before the University's Board of Regents, will bring his support of innovative medical science at the University of Michigan to a total of $100 million.
Researchers at Drexel University College of Medicine have discovered that a certain type of sugar found naturally in the body is elevated in breast cancer cells and is critical for cancer growth and movement. When researchers reduced and normalized the levels of this sugar, they were able to slow the growth of the cancer cells and block invasion. The findings, published in the March 1 issue of Oncogene, represent a potential new therapeutic target for treating aggressive forms of breast cancer.
Intellipharmaceutics International Inc. today announced that it has received purchase agreement commitments from institutional investors to provide the Company with approximately US$12,000,000 in gross proceeds through the sale of its common stock and warrants.
› Verified 6 days ago